findmyKOL

Lamont Weide, MD, PhD, FACE

Basic profile

University of Missouri–Kansas City

ORCIDNone on fileNPI
RegionKansas City, MO · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Lamont Weide is an Endocrinology/Metabolic physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 44 publications with 1,431 citations (h-index 15).

Overview

Scholarship

indexed output and impact (OpenAlex)
44publications

Distinct works indexed by OpenAlex.

1,431citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    41.9%
    Statin14.8%
    Atorvastatin Calcium74%Rosuvastatin Calcium17%Pravastatin Sodium7%Lovastatin2%
    Part D<11 patients
    Calcium channel blocker5.6%
    Amlodipine Besylate94%Nifedipine Er6%
    Part D<11 patients

    + 12 more classes in this area

  • Metabolism & gastrointestinal

    39.9%
    Insulin Analog11.1%
    Lantus Solostar36%Novolog Flexpen21%Humalog Kwikpen U-10011%Novolog7%Insulin Lispro Kwikpen U-1007%Tresiba Flextouch U-1006%Basaglar Kwikpen U-1006%Tresiba Flextouch U-2003%Humalog3%
    Part D<11 patients
    GLP-1 receptor agonist11.1%
    Trulicity47%Ozempic40%Victoza 3-Pak6%Rybelsus4%Victoza 2-Pak3%
    Part D<11 patients

    + 8 more classes in this area

  • Hormonal (systemic)

    14.7%
    l-Thyroxine12.9%
    Levothyroxine Sodium87%Synthroid13%
    Part D112 patients
    Thyroid Hormone Synthesis Inhibitor1.5%
    Methimazole100%
    Part D14 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”